News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sergio Cifuentes: Indirect Comparison between CM649 vs GASTFOX
Sergio Cifuentes/X
May 1, 2025, 11:33

Sergio Cifuentes: Indirect Comparison between CM649 vs GASTFOX

Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, shared a post on X:

“Indirect Comparison between CM649 vs GASTFOX. Really insightful discussion with MLP Oncología comparing the control arms across these two trials.”

Sergio Cifuentes: Indirect Comparison between CM649 vs GASTFOX

More posts featuring Sergio Cifuentes.

cancer CM649 fight against cancer GASTFOX Global fight against cancer MLP Oncología OncoDaily Oncology Sergio Cifuentes
Special Coverage
Insight
Aug 13, 2025, 07:15
Hadieh Eslampanah: Another Powerful Opportunity for MAHAK Institute
Science
Aug 13, 2025, 07:14
Emma M. Groarke: American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS
Voices
Aug 13, 2025, 07:14
Chair of CANCaRe Africa Working to Improve Care for Children with Cancer
Science
Aug 13, 2025, 07:01
Murali Janakiram: The Toxicity Profile of GPRC5D Bispecific Antibody Talquetamab
Societies
Aug 13, 2025, 06:35
NCI-funded Cancer Research Internship Positions Undergraduates for Success
Voices
Aug 13, 2025, 06:14
Wafaa M Rashed: African Women Scientists - Shaping the Future of Genomics in Africa
Societies
Aug 13, 2025, 05:56
How Reprogramming T Cell Energy Boosts Cancer-Fighting Power - Cancer Research Institute
Voices
Aug 13, 2025, 05:29
George Kumar: How Discovery of Monoclonal Antibodies Transformed Biomedical Science and Health Care
Insight
Aug 13, 2025, 05:14
Sylvester Comprehensive Cancer Center Researchers Uncover Molecular Drivers of Cellular Differentiation
Voices
Aug 13, 2025, 04:57
Are You Living With Small Cell Lung Cancer? - LUNGevity Foundation
Oncolibrary
Aug 13, 2025, 04:54
KEYNOTE-905 (EV-303) Trial Updates: Pembrolizumab Plus Enfortumab Vedotin Significantly Improves Survival in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Oncolibrary
Aug 13, 2025, 04:45
REGOMUNE Trial Comprehensive Overview in Advanced Solid Tumors